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Recent 2009 flu pandemic is a global outbreak of a new strain of influenza A virus subtype H1N1. The H1N1 virus has crossed species barrier to human 
and apparently acquired the capability to transmit this disease from human to human.  The NP is a multifunctional protein that not only encapsidates viral 
RNA (vRNA), but also forms homo-oligomer and thereby maintains RNP structure. It is also thought to be the key adaptor for virus and host cell 
interaction. Thus, it is one of the factor that play a key role in the pathogenesis of influenza A virus infection. Therefore, to understand the cause of 
pathogenicity of H1N1 virus, we have studied the structure-function relationship of different domains of NP. Our results showed that conservative 
mutation in NP of various strains were pathogenic in nature.  However, non-conservative mutation slightly abrogated oligomerization and was therefore 
less pathogenic. Our results also suggest that beside tail and body domain, head domain may also participate in an oligomerization process.  
 
 





Influenza A virus is a contagious respiratory illness causing annual 
epidemics and occasional pandemics killing million of people world-wide. 
Therefore, it possesses significant challenge to both human and animal 
health.  Recent 2009 flu pandemic is a global outbreak of a new strain of 
influenza A virus subtype H1N1 also commonly known as “swine flu” or 
“mexican flu”. The virus has emerged because of genetic reassortment of 
endemic strains of human, avian flu and swine flu [1-2]. The H1N1 virus 
has crossed species barrier to human and   apparently   acquired the 
capability to transmit this disease from human to human [3-4]. Influenza A 
virus belongs to the family of orthomyxoviridae. It is a lipid enveloped 
virus containing a negative-single stranded sense  RNA genome that are 
organized into eight separate segments which code for eleven proteins [5-
6].  
 
The nucleoprotein (NP) is located on segment 5 of the segmented negative-
strand RNA genome. The NP is the major component of the RNP, which is 
complex comprising of RNA, NP and RNA polymerase. The NP is a 
multifunctional protein that encapsidates viral RNA (vRNA) [7] as well as 
forms homo-oligomer and thereby maintains RNP structure [8]. It is also 
believed to be the key adaptor for virus and host cell interaction [9]. 
Recent study suggests a direct interaction of NP with polymerase proteins 
may be involved in regulating the switch of viral RNA synthesis from 
transcription to replication [10].  The nucleoprotein is an entirely an alpha 
helical protein that has head domain, body domain and tail. 
Oligomerization of the influenza virus nucleoprotein is mediated by a tail 
loop that is inserted into body domain of neighbouring NP molecule [11]. 
Thus, both tail and body domain participates in an oligomerization process. 
Proper self-association is important for the biological activities of 
nucleoprotein, because the R416A mutant was shown to be defective in 
RNA binding and also in viral RNA synthesis [12].The core protein 
nucleoprotein do not mutate as fast as surface protein HA, therefore this 
protein can serve as a suitable target for both drugs and antiviral vaccines 
developments. In view of above, we have identified mutations in different 
structural domains of NP and   we have deduced the effect of mutation on 
oligomerization.  Further, we have also analyzed mutations in the antigenic 
site. These studies revealed the structure-function relationship of NP and 
cause of the antigenic variations and pathogenicity.  
 
Methodology: 
The sequence of NP of influenza A virus A/New Mexico/04/2009(H1N1), 
from human was analyzed in this study. The NP is available at NCBI [13] 
with accession number [GenBank: ACR08594]. Protein protein blast [14] 
was performed at NCBI server. This sequence was aligned with other 
homologous sequence using Clustal W [15] multiple alignment tool using 
weight matrix GONNET. The multiple aligned sequences were analyzed 
for mutations in the amino acids at specific positions in different domains 
of NP.  Hydrophobicity values were obtained from the program ProtScale 
at ExPASy choosing Kyte & Doolittle hydrophobicity scale [16]. 




Structure-function studies of different domains of NP: 
The NP is a multifunctional protein that encapsidates vRNA through its 
RNA binding domain (residues 1-181) and form homo-oligomers. The 
nucleoprotein has NPI (residues189-358) and NPII (residues 371-465) 
binding domains important for mediating NP-NP contacts and thereby 
undergoes oligomerization [9]. It also has a PB2 binding domains [PB2-I 
(1-161), PB2-2(255-340) PB2-3(340-465][9]. These domains of NP 
interact with PB2 subunit of RNA polymerase. 
  
The NP sequence of   strain ACR08594 was compared with other strains of 
NP (Table 1 see supplementary material) showing 99.80% to 99.40% 
identity.  Thirteen sequences of NP of different strains were selected. 
Structural-functional relationship of different domains of NP was deduced 
in this study.  Our data of ACQ76390 strain shows that there was a 
mutation Val217 to Ile 217 in the head region of helix 4 (see 
supplementary material Table 1 [18]). Since, this is a conservative 
mutation that occurred at NP1 binding domain, it did not affect NP-NP 
contact and subsequent oligomerization [9]. Therefore, it did not affect 
oligomerization of NP. Other strain ACQ76337 showed mutation in the Bioinformation  Volume 5 
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body region of helix 4 in RNA binding region, which also overlaps PB2 
domain. This mutation causes in the substitution of Leu133 by an Ile133. 
This is also a conservative substitution. Hence, this strain binds RNA 
normally and interacted with PB2 normally. These strains were pathogenic 
in nature. 
 
The strain ACQ76327 has a mutation in the body of helix 16 in 
overlapping NPII and PB2 domains. Mutation causes in the substitution of 
hydrophobic Val 343 by a polar Thr343. The mutation is non-conservative, 
where microenvironment of both NP II and PB2 domains was changed. 
Therefore, this strain formed oligomer weakly and showed reduces 
interaction with PB2. These observations is supported  by the findings that 
oligomerization is important for NP function because R 416 A mutant was 
found defective in RNA binding and viral RNA synthesis [12]. There is 
also direct interaction of NP with PB2 [10]. These two strains were weakly 
pathogenic. 
 
In NP of ACS94528 strain, mutation occurred in the head region of helix 8 
in the NPII binding domain.  In this strain, there was a conservative 
substitution of Ile 189 by Val189. This leads to normal formation of NP-
NP homo-oligomer [9]  and hence this strain was pathogenic in nature. 
Similarly, the NP of strain ACQ76406 showed substitution Val 217 by Ile 
217 in the head region of helix 9 and another substitution Val343   by 
Leu343 in the body region of helix 16. These mutations are conservative 
mutations. Therefore, this strain formed NP-NP oligomer normally and 
interacted with PB2 normally. The NP of other strain ACR67140 has a 
mutation located in the helix 10 of head region in the PB2 domain. This is 
a also a conservative substitution, Ala234 by Val234, and it did not affect 
oligomerization or interaction with PB2. These observations are supported 
by the findings that self-association or oligomerization is important for NP 
function [12] and there is also direct interaction of NP with PB2 [10].  
 
The NP of strain ACQ63285 carried mutation in the head region of helix 
11 in NPII and PB2 domains, where hydrophobic Ala 251 is substituted by 
polar Thr 251. This is a non-conservative substitution where 
hydrophobicity decreased in overlapping NPII and PB2 domains. 
Therefore, this leads to decrease in the formation of NP-NP homo-
oligomer and poor interaction with PB2.  Similarly, the NP of strains 
ACS14690 and ACQ76377 showed mutation in the head region of helix 
19.  The polar Ser450 is substituted by an amide derivative of acidic amino 
acid Asn450. These strains showed loss of NP-NP oligomer formation and 
interaction with PB2. All of these strains were weakly pathogenic. These 
results imply that self association is important for NP function [12]. 
Furthermore, mutational study has shown that mutant NP has a reduced 
capability to interact with the polymerase complex and that this NP-
polymerase interaction is responsible for making vRNPs switch from 
mRNA to cRNA synthesis [19]. A mutation in the body region of helix 12 
in the NP and PB2 binding domains is seen in ACR67161 strain.  The 
hydrophobic Leu283 is replaced by a cyclic imino acid Pro283.  Since Leu 
283 is a strong helix former, whereas Pro283 is a helix breaker.  This leads 
to alteration of α-helix 12 and consequently overall conformation of 
nucleoprotein was slightly changed. Hence, it formed homo-oligomer 
weakly and showed poor interaction with PB2 [12, 10]. This strain was 
weakly pathogenic. 
 
In NP of eight strains, Ile 373→Thr 373 mutations were found conserved 
(see supplementary material Table 2).  In all of these strains, 
hydrophobic Ile is substituted by polar Thr.  This is a non-conservative 
mutation. Besides this, six strains also showed a new mutation 
Val100→Ile100 which was found conserved in several strains (see 
supplementary material Table 2).These results imply that due to the 
presence of multiple mutations in the NP of these strains (see 
supplementary material Table 2), the conformation of NP was  altered 
significantly. Hence these strains formed homo-oligomer weakly [12] and 
interacted with PB2 poorly [10]. This leads to some loss of RNP structure 
as well. Consequently, it inhibited the switch of genomic vRNA synthesis 
from transcription to replication. These strains showed weak pathogenicity. 
None of the mutations we observed occurred in tail-loop, which play an 
important role in oligomerization by inserting inside a body domain of 
neighbouring molecule.  Our results showed non-conservative mutation in 
the head domain causes in the inhibition of oligomerization. This implies 
that head domain may also participate in an oligomerization process.   
Strains carrying conservative mutations showed that NP domains have 
native like structure, therefore these strains were virulent. Contrary to this, 
strains possessing non-conservative mutations in domains showed a slight 
loss of structure. Therefore, these strains were weakly pathogenic. 
 
Antigenicity: 
The computer program “Antigenic” predicted 14 antigenic segments in NP 
of ACR08594 strain (See supplementary material - Table 3). This 
antigenic profile was found conserved in all strains except ACR77442, 
ACQ76384 and ACR67140.  The NP of these strains namely ACR77442 
and ACQ76384 showed mutation Val183→Met183 and Val352→Met352 
respectively. Therefore, corresponding antigenic segments 179-189 and 
349-356 were missing. Conversly, ACR67140 strain showed mutation Ala 
234→Val234 and consequently there was a gain of an antigenic site 231-
236. These are    major source of antigenic variations in NP.  
 
Conclusion: 
These results suggest that head domain of NP may also participate in an 
oligomerization process. These results also conclusively showed that 
conservative mutation in NP is  more pathogenic than non-conservative 
mutation. Thus, our hypothesis confirms the structure-function relationship 
of NP. Loss or gain of an antigenic site represents  a source of  antigenic 
variations in NP.  
 
Acknowledgements: 
This work was supported by the DBT grant sanction no. 
BT/PR7507/BID/07/201/2006 to AUK. Authors are also grateful  to  Prof. 
M Saleemuddin for providing the internal fund for this project. 
 
References: 
[1]  AU Khan, Bioinformation 4:52 (2009) [PMID: 20011154] 
[2]  P Salahuddin & AU Khan, Bioinformation 4:30  (2009) [PMID: 
20011150] 
[3]  D Butler, Nature 458:1082 (2009)  [PMID: 19407756] 
[4]  I Cohen & M Enserink, Science 324:572 (2009) [ PMID: 
19407164] 
[5]  D Kobasa & Y Kawaoka, Curr  Mol  Med 5:791 (2009) [PMID: 
16375713] 
[6]  JC Obenauer et al. Science  311:1576 (2006)  [PMID: 16439620] 
[7]  M Kobayashi  et al. J Virol. 68:8433 (1994) [ PMID: 7966640] 
[8]  EN Prokudina-Kantorovich NP Semenova,Virology  223:51(1996)[ 
PMID: 8806539] 
[9]  A Portela & P Digard, J Gen Virol  83:723 (2002) [PMID: 
11907320] 
[10]  SK Biswas et al. J Virol 72:5493 (1998) [ PMID: 9621005] 
[11]  Q Ye et al. Nature  444:1078(2006) [ PMID: 17151603] 
[12]  D Elton et al. J Virol 73: 7357 (1999) [ PMID: 10438825] 
[13]  http://www.ncbi.nlm.nih.gov/ 
[14]  http://www.ncbi.nlm.nih.gov/BLAST/ 
[15]  http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_clustalw.html 
[16]  http://www.expasy.org/tools/protscale.html 
[17]  http://liv.bmc.uu.se/cgi-bin/emboss/antigenic 
[18]  K Ng  et al. Sci China C Life Sci. 52:439(2009) [ PMID: 19471866] 
[19]  I  Mena et al. J Virol.73:1186(1999) [ PMID: 9882320] 
Edited by P. Kangueane 
Salahuddin & Khan, Bioinformation, 5 (1) 25-30, 2010 
License statement: This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial 
purposes, provided the original author and source are credited. Bioinformation Volume 5 
open access 
www.bioinformation.net  Issue 1  Hypothesis
   
   
Supplementary material: 
 
Table 1: Nucleoprotein sequence dataset from human source 
Strain  Gene Accession No     Country 
A/New Mexico/04/2009(H1N1)             ACR08594  Mexico 
A/Nebraska/02/2009(H1N1)                    ACQ76390  U.S.A. 
A/Kansas/03/2009(H1N1) ACQ76337  U.S.A. 
A/Indiana/09/2009(H1N1)  ACQ76377             U.S.A. 
A/South Carolina/09/2009(H1N1)  ACQ76327    U.S.A. 
A/New York/58/2009(H1N1)    ACS94528    U.S.A. 
A/Colorado/03/2009(H1N1) ACQ76406  U.S.A. 
A/New York/3189/2009(H1N1)  ACR77442  U.S.A. 
A/Missouri/01/2009(H1N1)   ACR67140  U.S.A. 
A/Ohio/07/2009(H1N1 ACQ76384  U.S.A. 
A/Ohio/07/2009(H1N1) ACQ63285  U.S.A. 
A/New York/3210/2009(H1N1)  ACS14690  U.S.A. 
A/South Dakota/05/2009(H1N1)  ACR67161  U.S.A. 
 
Table 2: Amino acid mutations in Nucleoprotein of different strains at specific positions and their location in different domains  
Gene Acession          Mutation at specific position      Location of mutation in domain  Hydrophobicity change (Kyte & Doolittle) 
ACQ76390 V217→I217                      Head  -1.944 →-1.911 
ACQ76337 L133→ I133  Body      +0.978→+1.056 
S450 →N450                      Head      -1356→-1.656  ACQ76377     
V363→I363                            -  -0.022→+0.011 
V343 →I343 Body  +0.224→+0.278  ACQ76327             
I 373→T373 -  -0.856→-1.433 
V100→I100 -  1.144→-1.111 
I373→t373 -  -0.856→-1.433 
ACS94528  
I189→V189 Head  +1.224→+1.211 
V217→I217 Head  -1.914→-1.911 
V343→I343 Body  +0.244→+0.278 
ACQ76406  
I373→T373 -  -0.856→-1.433 
V100→I100                           -  -1.144→-1.111 
V183→M183 -  +0.967→+0.711 
ACR77442 
  
I373→T373   -  -0.856→-1.433 
A234→V234       Head                                         -0.233→+0.033  ACR67140 
I373→T373                         -  -0.856→-1.433 
V100→I100 -  -1.144→-1.111 
I373→T373 -  -0.856→-1.433 
ACQ76384 
V352→M352 -  -1.167→-1.422 
V100 →I100 -  -1.144→-1.111 
A251→T251 Head  -1.467→-1.744 
ACQ63285 
I373→T373 -  -0.856→-1.433 
V100→I100 -  -1.144→-1.111 
I373→T373 -  -0.856→-1.433 
ACS14690 
S450→N450 Head  -1.356→-1.656 
L283→P283 Body  +1.756→+1.156  ACR67161 
I373→T373 -  -0.856→-1.433 
 
Table 3: Predicted antigenic sites in human Nucleoprotein (A/New Mexico/04/2009(H1N1)) and in other strains 
Amino acid position  Antigenic Segment           Total no of amino acid residues         Score 
254->288 EDLIFLARSALILRGSVAHKSCLPACVYGLAVASG  35  1.249 
325->346 KSQLVWMACHSAAFEDLRVSSF 22  1.133 
296->316 YSLVGIDPFKLLQNSQVVSLM  21  1.126 
403->417 AGQISVQPTFSVQRN  15  1.122 
473->479 NPIVPSF    7  1.090 
38->50 RFYIQMCTELKLS  13  1.088 
179->189 AGAAVKGVGTI  11  1.082 
349->356 GKKVIPRG    8  1.075 
64->71 ERMVLSAF  8  1.074 
107->113 ELILYDK  7  1.066 
360->366 TRGVQIA  7  1.053 
151->156                TRALVR    6  1.052 
222->229 MCNILKGK  8  1.046 
132->138 GLTHIMI  7  1.041 
ACR77442 
179->189 
AGAAVKGVGTI    
(Antigenic Segment missing) 
- - 
ACQ76384 
349->356        
GKKVIPRG 





(Gain of Antigenic Segment) 
 
- - 
 